MX2009013482A - Derivados de [1,10]-fenantrolina para el tratamiento de enfermedades neurodegenerativas o hematologicas. - Google Patents

Derivados de [1,10]-fenantrolina para el tratamiento de enfermedades neurodegenerativas o hematologicas.

Info

Publication number
MX2009013482A
MX2009013482A MX2009013482A MX2009013482A MX2009013482A MX 2009013482 A MX2009013482 A MX 2009013482A MX 2009013482 A MX2009013482 A MX 2009013482A MX 2009013482 A MX2009013482 A MX 2009013482A MX 2009013482 A MX2009013482 A MX 2009013482A
Authority
MX
Mexico
Prior art keywords
neurodegenerative
treatment
phenanthroline derivatives
haematological diseases
haematological
Prior art date
Application number
MX2009013482A
Other languages
English (en)
Inventor
Laura Rubio Arrieta
Miguel Medina Padilla
Ana Castro Morera
Esther Garcia Palomero
Paola Usan Egea
Ana Martines Gil
Jorge Sanchez-Quesada
Mercedes Alonso Cascon
Original Assignee
Noscira Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Noscira Sa filed Critical Noscira Sa
Publication of MX2009013482A publication Critical patent/MX2009013482A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

La presente invención se refiere a una nueva familia de derivados de [1,10]-fenantrolina de fórmula (I), que son útiles para el tratamiento o la profilaxis de una enfermedad o estado neurodegenerativo o hematológico, su uso como un medicamento, especialmente para tratar una enfermedad o estado neurodegenerativo o hematológico con tratamiento, y una composición farmacéutica que comprende los compuestos. (Ver fórmula I).
MX2009013482A 2007-06-11 2008-06-11 Derivados de [1,10]-fenantrolina para el tratamiento de enfermedades neurodegenerativas o hematologicas. MX2009013482A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07380167A EP2002863A1 (en) 2007-06-11 2007-06-11 [1,10]-phenanthroline derivatives for the treatment of neurodegenerative or haematological diseases
PCT/EP2008/057319 WO2008152068A2 (en) 2007-06-11 2008-06-11 [1,10]-phenanthroline derivatives for the treatment of neurodegenerative or haematological diseases

Publications (1)

Publication Number Publication Date
MX2009013482A true MX2009013482A (es) 2010-01-27

Family

ID=38596362

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009013482A MX2009013482A (es) 2007-06-11 2008-06-11 Derivados de [1,10]-fenantrolina para el tratamiento de enfermedades neurodegenerativas o hematologicas.

Country Status (13)

Country Link
US (2) US8592446B2 (es)
EP (2) EP2002863A1 (es)
JP (1) JP2010529167A (es)
CN (1) CN101801461A (es)
AR (1) AR066956A1 (es)
AU (1) AU2008263897A1 (es)
CA (1) CA2690455A1 (es)
CL (1) CL2008001719A1 (es)
MX (1) MX2009013482A (es)
RU (1) RU2009148821A (es)
TW (1) TW200914016A (es)
UY (1) UY31143A1 (es)
WO (1) WO2008152068A2 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012071791A1 (zh) 2010-12-01 2012-06-07 中国石油化工股份有限公司 一种n邻位酰基取代的含氮杂环化合物及其缩胺合铁(ii)配合物的制备方法
CN102532201B (zh) * 2010-12-01 2014-11-05 中国石油化工股份有限公司 甲酰基取代的1,10-菲咯啉配合物的制备及由此制备的配合物作为催化剂的应用
CN102558241B (zh) * 2010-12-01 2014-11-26 中国石油化工股份有限公司 丙酰基取代的1,10-菲咯啉配合物的制备及由此制备的配合物作为催化剂的应用
CN106083713B (zh) * 2016-07-15 2019-07-26 浙江工业大学 一种喹(喔)啉-2-甲醛类化合物的化学合成方法
WO2021176428A1 (en) * 2020-03-06 2021-09-10 Jawaharlal Nehru Centre For Advanced Scientific Research Phenanthroline, carbazole and flavylium based cyanines and compositions and methods of making and using the same
CA3232921A1 (en) * 2021-09-28 2023-04-06 Zevra Denmark A/S Oximes and their use in treatment of gba-related diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL76345B1 (es) * 1971-02-13 1975-06-30

Also Published As

Publication number Publication date
AR066956A1 (es) 2009-09-23
WO2008152068A2 (en) 2008-12-18
RU2009148821A (ru) 2011-07-20
CL2008001719A1 (es) 2009-01-02
US20100240692A1 (en) 2010-09-23
US8592446B2 (en) 2013-11-26
AU2008263897A1 (en) 2008-12-18
JP2010529167A (ja) 2010-08-26
EP2170464A2 (en) 2010-04-07
WO2008152068A3 (en) 2009-05-07
TW200914016A (en) 2009-04-01
CN101801461A (zh) 2010-08-11
US20140011835A1 (en) 2014-01-09
EP2002863A1 (en) 2008-12-17
CA2690455A1 (en) 2008-12-18
UY31143A1 (es) 2009-01-30

Similar Documents

Publication Publication Date Title
MY155649A (en) Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease
MX2010009752A (es) Compuestos de oxadiazoantraceno para el tratamiento de diabetes.
PL2150530T3 (pl) Podstawione pochodne sulfonamidu
TN2013000285A1 (en) Novel heterocyclic derivatives and their use in the treatment of neurological disorders
WO2007068894A3 (en) Substituted diphenylethers, -amines, -sulfides and -methanes for the treatment of respiratory disease
BRPI0610850A2 (pt) derivados de Ácido aril alquila, composiÇço farmacÊutica, medicamento, bem como uso dos referidos derivados
TW200745043A (en) Substituted pyrazoline compounds, their preparation and use as medicaments
MX2009004908A (es) Compuestos quimicos.
MY179527A (en) Catecholamine derivatives useful for the treatment of parkinson's disease
WO2007009723A3 (en) Azepane- or azocane-substituted pyrazoline derivatives, their preparation and use as medicaments
UA104988C2 (uk) Похідні піроніндолу та спосіб їх отримання
WO2007009720A3 (en) Prodrugs of pyrazoline compounds, their preparation and use as medicaments
TW200736189A (en) Indene derivatives, their preparation and use as medicaments
GB0620385D0 (en) Novel compounds
WO2009025785A3 (en) Cb2 receptor ligands for the treatment of pain
MX367131B (es) Sales de xantilio 3,6-disustituidas.
MX2010003269A (es) Derivados de pirrolotriazina utiles para tratar cancer a traves de la inhibicion de la aurora quinasa.
WO2009003719A3 (en) Indane-amine derivatives, their preparation and use as medicaments
MX2009010374A (es) Derivados de tetrahidro-naftalenamina sustituidos con heterociclilo, su preparacion y su uso como medicamentos.
MX2009013482A (es) Derivados de [1,10]-fenantrolina para el tratamiento de enfermedades neurodegenerativas o hematologicas.
TW200745042A (en) Substituted pyrazoline compounds, their preparation and use as medicaments
MX2009007889A (es) Derivados de 3-cinnolincarboxamida y su uso para el tratamiento del cancer.
WO2008043788A3 (en) Novel compounds
DE602007007934D1 (en) Imidazoazephinonverbindungen
TW200738611A (en) 9-Chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments

Legal Events

Date Code Title Description
FA Abandonment or withdrawal